Bimekizumab versus Adalimumab in Plaque Psoriasis

To the Editor: The trial reported by Warren and colleagues (July 8 issue) 1 showed that bimekizumab was superior to adalimumab in reducing cutaneous symptoms of plaque psoriasis but was associated with a higher incidence of oral candidiasis and diarrhea. The prevalence of psoriasis among persons 20...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The New England journal of medicine 2021-09, Vol.385 (12), p.1149-1150
Hauptverfasser:	Griffith, Shantelle K, Ahn, Grace S, Wu, Jashin J, Warren, Richard B, Cioffi, Christopher, Peterson, Luke
Format:	Artikel
Sprache:	eng
Schlagworte:	Candidiasis Conflicts of interest Diarrhea Hispanic Americans Monoclonal antibodies Population Psoriasis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!